ArticlePDF Available

Colorectal cancer epidemiology in an area with a spontaneous screening program

Authors:

Abstract and Figures

The aim of this study was to analyze and describe the epidemiological characteristics and trends of colorectal cancer in Sassari province (Sardinia, Italy), an area with a spontaneous surveillance program for colorectal malignancies, in the period 1992-2010. Data were obtained from the local tumor registry which makes part of a wider registry web, coordinated, today, by the Italian Association for Tumor Registries. The overall number of colorectal cancer cases registered was 4.284. The male-to-female ratio was 1:0.7 and the mean age 68.3 years for males and 69.4 years for females. The standardized incidence rates were 49.3/100,000 and 31.1/100,000 and the standardized mortality rates 20.4/100,000 and 12.4/100,000 for males and females respectively. An increasing trend in the incidence of colorectal cancer in Sassari province was evidenced. Relative survival at 5 years from diagnosis was 48.6% (52.3% for males and 44.7% for females). A slight increase in mortality rates was observed, as opposed to national figures, probably attributable to the lacking of organized screening strategies in the area.
Content may be subject to copyright.
COLORECTAL CANCER EPIDEMIOLOGY IN AN AREA WITH A SPONTANEOUS SCREENING
PROGRAM
GIUSEPPE PALMIERI*, PANAGIOTIS PALIOGIANNIS**, FABRIZIO SCOGNAMILLO**, MARIO BUDRONI***, ROSARIA CESARACCIO***,
FABIO PULIGHE**, FRANCESCO TANDA**, MARIO TRIGNANO**, ANTONIO COSSU**
*Institute of Biomolecular Chemistry, Cancer Genetics Unit, C.N.R. Sassari - **Department of Surgical, Microsurgical and Medical
Sciences, University of Sassari, - ***Service of Epidemiology, A.S.L. 1, Italy
[Epidemiologia del cancro colo-rettale in un’area con screening spontaneo]
Introduction
Colorectal cancer is one of the most common
neoplastic diseases in the world with more than
1,200,000 cases in 2008(1). It is the third most inci-
dent neoplastic disease in both sexes, after lung and
prostate cancer in men and breast and cervix cancer
in women(1). It also represents the fourth most fre-
quent neoplastic cause of death after lung, stomach
and liver cancer(1). A consistent and worldwide
increase in colorectal cancer was registered in the
last decades(2,3). This increase may reflect technolog-
ical improvements in modern diagnostic methods
and changes in dietary habits and other risk factors,
as well as continuous improvement of the expectan-
cy of life(3,4,5). Otherwise, the progressive adoption
of screening programs in western countries, useful
to identify individuals with pre-symptomatic neo-
plastic colorectal lesions, should reduce the mortali-
ty for colorectal cancer(4,6,7).
The aim of this population-based study was to
analyze and describe the epidemiological character-
istics and trends of colorectal cancer in the province
of Sassari (Sardinia, Italy), in the period 1992-
2010.
Materials and methods
The epidemiological data presented in this
article were obtained from the “Registry of the
tumors of the Province of Sassari”. This registry
was created in 1992 by the local health agency for
the epidemiological surveillance of tumors. In 1999
it became part of a wider web of tumor registries,
coordinated, today, by the Italian Association for
Tumor Registries (Associazione Italiana Registri
Tumori, AIRTUM). The association coordinates 34
registries in the country, collects and publishes data,
and collaborates with international organizations in
the field.
Every registry collects data on tumoral dis-
eases affecting inhabitants in the territory of juris-
diction through the local hospitals and health care
services, as with other registries (e.g., death regi-
Acta Medica Mediterranea, 2013, 29: 231
ABSTRACT
The aim of this study was to analyze and describe the epidemiological characteristics and trends of colorectal cancer in
Sassari province (Sardinia, Italy), an area with a spontaneous surveillance program for colorectal malignancies, in the period
1992–2010. Data were obtained from the local tumor registry which makes part of a wider registry web, coordinated, today, by the
Italian Association for Tumor Registries. The overall number of colorectal cancer cases registered was 4.284. The male-to-female
ratio was 1:0.7 and the mean age 68.3 years for males and 69.4 years for females. The standardized incidence rates were
49.3/100,000 and 31.1/100,000 and the standardized mortality rates 20.4/100,000 and 12.4/100,000 for males and females respec-
tively. An increasing trend in the incidence of colorectal cancer in Sassari province was evidenced. Relative survival at 5 years from
diagnosis was 48.6% (52.3% for males and 44.7% for females). A slight increase in mortality rates was observed, as opposed to
national figures, probably attributable to the lacking of organized screening strategies in the area.
Key words: Colorectal cancer, adenocarcinoma, screening, surveillance, Sassari.
Received March 11, 2013; Accepted March 26, 2013
232 G. Palmieri, P. Paliogiannis et Al
stries). Demographic, clinical, pathological and
prognostic data are collected for each case of can-
cer and are registered in a digital database. This
database was the data source for the present popula-
tion-based report.
The demographic characteristics of the
patients affected by colorectal cancer were collect-
ed. Crude incidence and mortality rates per 100,000
inhabitants per year were calculated, as were the
standardized rates adjusted for European population
standards. A comparison between incidence and
mortality in the province of Sassari and those in
other Italian provinces was performed.
Additionally, the cumulative risk of developing the
disease and of dying between zero and 74 years of
age was estimated. The age class distribution and
time trends of incidence, mortality, and histology
were also evaluated. Finally, relative 5-year sur-
vival was calculated.
Results
The overall number of cases of colorectal can-
cer registered in the period under investigation was
4,284. Diagnosis was obtained by histological or
cytological reports in 3,945 cases (92.1%) and
using other information sources (clinical reports,
radiological referrals, death certifications, etc) in
326 cases (7.6%). The modality of diagnosis was
not known in 13 cases (0.3%). Among the 4,284
individuals registered, 2,419 were males and 1865
females, with a male-to-female ratio of 1:0.77. The
mean age was 68.3 years for males and 69.4 years
for females. The cumulative risk of developing the
disease was 4.09% for males and 2.44% for
females.
As regards the anatomical distribution of the
tumors 959 (22.4%) were sited in the right colon,
177 (4.1%) in the transverse colon, 427 (10%) in the
left colon, 1,068 (24.9%) in the sigmoid colon and
1,422 (33.2%) in the rectum and anus, while in 231
(5.4%) cases the anatomical site of origin was not
known. Among the 3,945 tumors that had histologi-
cal or cytological diagnosis, 3785 (95.9%) were ade-
nocarcinomas, while only 97 (2.5%) were lesions of
a different histotype. In the remaining 63 (1.6%)
cases the exact histologic type was not specified.
The crude incidence of colorectal malignan-
cies in the period under investigation was
58.9/100,000 for men and 43.9/100,000 for women.
Standardized incidence rates were 49.3/100,000 for
males and 31.1/100,000 for females.
Table 1 shows the distribution of incidence in
relation to age in percentages, while Table 2 shows
the distribution of incidence rates in relation to age.
Peak incidence occurred at 80-84 years for both
males and females. Incidence rates were also calcu-
lated for the following three time periods: 1992-
1998, 1999-2004 and 2005-2010 (Figure 1). There
was a progressive increase in incidence rate in
males, from 41.35/100,000 in the first period, to
50.47/100,000 in the second period and
56.76/100,000 in the last period. The corresponding
figures for females were 27.5/100,000,
30.75/100,000 and 35.44/100,000, respectively. A
steady increase in incidence occurred between 1992
and 2010. Analysis of the trend of mean age at dis-
ease onset for the same periods of time did not
reveal any relevant changes (Figure 2).
Age (years) Males
(Incidence %)
Femmales
(Incidence %)
0-14 0 0
15-29 0.16 0.43
30-44 3.27 3.59
45-59 17.3 17.27
60-74 48.7 40.16
75+ 30.84 38.55
Table 1: Age-class incidence distribution.
Age (years) Incidence
(/100,000)
(Incidence)
(/100,000)
Males Females Males Females
0-14 0 00 0
5-9 0 00 0
10-14 0 00 0
15-19 0 0.4 0.4 0
20-24 0.3 0.7 0 0
25-29 0.9 1.6 00.3
30-34 4.7 3.5 0.3 0.9
35-39 5.1 5.1 2.4 0.9
40-44 14.5 12 3.8 1.9
45-49 25.4 19.1 8.1 5.1
50-54 50.3 43.9 13.7 9.9
55-59 81.4 56.8 30 17.9
60-64 141.8 89.8 39.2 27.1
65-69 213.7 121.5 76.9 44.6
70-74 294.7 140.3 113.5 62.5
75-79 312.4 184.3 165.4 85.1
80-84 378.1 229.4 212.2 125.4
85+ 284.3 215.4 274.4 207.8
Total 58.9 43.9 25.1 19.7
Table 2: Age-class incidence and mortality rates.
Table 3 shows the comparison of the incidence
and mortality in the province of Sassari with those
in other Italian provinces. There were 1868 deaths
in the period under investigation (1032 males and
836 females). Crude overall mortality was
25.1/100,000 for males and 19.7/100,000 for
females. Mean age at death was 71.8 years in males
and 74.5 years in females. Standardized mortality
rates were 20.4/100,000 for males and 12.4/100,000
for females. The cumulative risk of death was rela-
tively low (1.43% for males and 0.85% for
females). Table 2 shows the age-class distribution
of mortality rates. There was a relevant increase in
mortality rates after the sixth decade of life. Figure
1 shows the time trend of mortality between 1992
and 2010: a significant increase in mortality was
registered. Finally, relative survival at 5 years from
diagnosis was 48.6% (52.3% for males and 44.7%
for females).
Discussion
Colorectal cancer is the third most incident
neoplastic disease in the world, after lung and
breast cancer, with more than 1,200,000 cases in
2008(1). World population age-standardized inci-
dence calculated for the same year was
17.2/100,000 (20.3/100,000 for men and
14.6/100,000 for women), while cumulative risk
was 1.96%(1). Colorectal cancer is also the fourth
most frequent cause of neoplastic death, with more
than 600,000 deaths in the world in 2008(1).
Large part of these figures seems to involve
the most developed countries. In the European
Union more than 300,000 cases of colorectal cancer
were estimated in 2008, with a standardized inci-
dence of 31.7/100,000 inhabitants (39.9/100,000 for
men and 25.2/100,000 for women). There were
approximately 150,000 deaths, with standardized
mortality rate of 12.6/100,000 (16.3/100,000 for
males and 9.7/100,000 for females). The highest
figures were observed in countries of the central
Europe (Slovakia, Hungary, Czech Republic)(1,4).
Italy is one of the European countries with relative-
ly high colorectal cancer incidence, while Italian
figures for mortality are within mean European val-
ues. In 2008, more than 50,000 cases were observed
in the country and standardized incidence and mor-
tality rates were 35.5/100,000 and 11.7/100,000
respectively. In the same year more than 19,000
deaths for colorectal cancer were estimated in the
country(1). Data collected by AIRTUM (Table 3)
show slightly higher figures than those reported by
Globocan.
Standardized incidence rates in the province of
Sassari were lower than those estimated for the
entire country (Table 3). Comparisons of the inci-
dence rates with those of other Italian provinces
place our province between those with low inci-
dence rates, such as Napoli and Salerno. Provinces
with higher incidences, like Ferrara, Friuli Venezia
Giulia and Firenze, were generally northern ones.
Colorectal cancer epidemiology in an area with a spontaneous screening program 233
Figure 1: Incidence and mortality rates trends.
Figure 2: Trends of mean age at disease onset and death.
Males Females
Incidence Mortality Incidence Mortality
Alto Adige 65.7 29.3 42.3 16.3
Biella 59.3 26.9 37.4 15.9
Ferrara 75.6 31.8 46.8 18.6
Firenze 70.2 24.7 45.5 17.5
Friuli VG 74 29.7 46.5 15.1
Genova 67 28.1 43.1 14.4
Macerata 60.1 26.4 38.2 15.3
Modena 66.2 26.2 42.3 16.7
Napoli 42.6 19.5 28.7 12.3
Parma 63.6 23 38.5 12.1
Ragusa 48.7 20.5 31 12.9
Reggio E 64.6 22.2 41.1 17.1
Romagna 68.5 25.3 43.5 16
Salerno 42 16.3 27.9 11.4
Sassari 49.3 20.4 31.1 12.4
Torino 63.8 26.4 39.1 12.7
Trento 63.8 29 39.3 17.6
Umbria 69.9 25 45.5 15.7
Varese 62.5 27.8 38.3 13.6
Veneto 63.9 25 40,2 15.9
Mean 64.5 25.3 40.6 15.1
Table 3: Comparison with incidence and mortality rates
of other Italian provinces.
These figures may be probably due to dietetic fac-
tors, such as diffuse consumption of quality ali-
ments, especially vegetables, oil and wine.
Considering the distribution of the disease in
relation to age, less than 10% of the cases occurred
in individuals 30 years, while more than 75%
occurred after the sixth decade of life. Incidence
rates increased with aging in both sexes, reaching
peak values in individuals 80 years.
The time trends analysis showed a steady
increase in incidence in Sassari province in the peri-
od under investigation. This trend is common to sev-
eral national and international geographical areas,
which have contributed to the global increase in the
number of new colorectal cancer cases reported in
literature. It is not clear whether this is a real increase
in incidence or whether it reflects a general advanc-
ing in the technological means employed for diagno-
sis, an improvement and diffusion of endoscopic cul-
ture, or a progressively wider adoption of surveil-
lance programs in western countries.
Concerning mortality, 1868 (1032 males and
836 females) deaths occurred in the 18 years we
studied. Standardized mortality rates were consider-
ably lower for women and globally lower to those
observed in most provinces in Italy, but higher than
some recent European and world estimates(1).
Considering the age-class mortality trend, a natural
increase in relation to age could be observed in both
sexes, with peaks after the eighth decade of life and
with a slight increase between 1992 and 2010.
Screening strategies, both with faecal occult
blood tests or colonoscopy, can progressively
reduce colorectal cancer mortality, especially if
adequately organized(6,8). Indeed, in the United
States, where organized screening programs have
been started earlier, mortality rates are significantly
lower than in European or Asian countries that
adopted surveillance programs later. In our
province surveillance is performed through a spon-
taneous system adopted in the last decade, with no
charges for a faecal occult blood test and/or a
colonoscopy for individuals 50 years; an orga-
nized screening program for colorectal cancer is not
yet available. This may be the explanation of a
slightly increasing mortality trend observed in the
area in the last two decades, as adhesion rates to
spontaneous campaigns can be considerably vari-
able. Conversely, a slight reduction in mortality
rates for colorectal cancer was globally observed in
Italy in the last decades, both for males and
females, parallel to a progressively increasing num-
ber of screening programs in the various provinces
of the country(9,10). Finally, relative survival at 5
years from diagnosis was relatively low (48.6%),
furthermore suggesting the need to enhance prima-
ry prevention.
Conclusions
Our data point out an increasing trend in inci-
dence of colorectal cancer in Sassari province in the
last decades. However, incidence rates were lower
than those of other Italian provinces, especially
those of north Italy. Furthermore, a slightly increas-
ing trend in mortality rates was observed in both
sexes, as opposed to national figures, probably
attributable to the lacking of organized screening
strategies in Sassari province.
References
1) Globocan 2008, http://globocan.iarc.fr, 2012.
2) Grande E, Inghelmann R, Francisci S, Verdecchia A,
Micheli A, Baili P, Capocaccia R, De Angelis R.
Regional estimates of colorectal burden in Italy.
Tumori 2007; 93: 352-9.
3) Béjar LM, Gili M, Infantes B, Marcott PF. Incidence of
colorectal cancer and influence of dietary habits in fif-
teen European countries f om 1971 to 2002. Gac Sanit
2012; 26: 69-73.
4) Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J,
Seifert B, Fric P. Colorectal cancer screening in
Europe. World J Gastroenterol 2009; 15: 5907-15.
5) Haggar FA, Boushey RP. Colorectal cancer epidemiol-
ogy: incidence, mortality, survival, and risk factors.
Clin Colon Rectal Surg 2009; 4: 191-7.
6) Logan RF, Patnick J, Nickerson C et al. English Bowel
Cancer Screening Evaluation Committee, “Outcomes
of the Bowel Cancer Screening Programme (BCSP) in
England after the first 1 million tests. Gut 2012; 10:
1439-46.
7) Quintero E, Saito Y, Hassan C, Senore C. Colorectal
cancer screening. Gastroenterol Res Pract 2012;
DOI:10.1155/2012/476065.
8) Hewitson P, Glasziou P, Watson E, Towler B, Irwig L.
Cochrane systematic review of colorectal cancer
screening using the fecal occult blood test (hemoccult):
an update. Am J Gastroenterol 2008; 103: 1541-9.
9) I numeri del cancro in Italia 2012, http://www.registri-
tumori.it/cms/it/node/2537, 2012.
10) Zorzi M, Baracco S, Fedato C, Grazzini G, Sassoli De'
Bianchi P, Senore C, Visioli CB, Cogo C. Screening for
colorectal cancer in Italy, 2009 survey. Epidemiol Prev
2011; 35: 55-77.
_________
Request reprints from:
Dr. Panagiotis Paliogiannis MD.
Department of Surgical
Microsurgical and Medical Sciences
University of Sassari
Sassari
(Italy)
234 G. Palmieri, P. Paliogiannis et Al
... Despite extensive knowledge of CRC biology and improvements in therapy and in population-based screening, it remains one of the hard-to-treat cancers considering the high AE treatment-related adverse events, CI confidence interval, D durvalumab, ORR objective response rate, OS m median overall survival, PFS m median progression-free survival, SoC standard of care, T tremelimumab frequency of metastases and recurrences after surgery, and frequent resistance to first-or second-line of treatment [63]. In fact, chemotherapy has been the main treatment in the past decades; survival rates have begun to increase with the introduction of targeted monoclonal antibodies [64]. ...
Article
Full-text available
Introduction. Cancer immunotherapy represents one of the most important innovation in modern medicine. Durvalumab is an anti-PDL-1 agent which is currently under investigation in several studies in combination with the anti-CTLA-4 drug Tremelimumab. The aim of this review was to systematically identify and revise the current scientific literature investigating the combination of these two drugs in solid tumors. Materials and Method. A digital research on the Medline (PubMed interface) and Scopus databases for articles published from inception to 26 February 2021, has been performed. The terms used for the research were (Durvalumab) AND (Tremelimumab). English language trials involving adult patients with solid cancers treated with the combination Durvalumab plus Tremelimumab were retrieved; the references of the articles were cross-checked to identify missing papers. Results. The electronic research produced 267 results; after excluding duplicates, irrelevant, reviews and papers not in English or missing data, 19 articles were included for revision. The total number of patients treated with the combination of Durvalumab and Tremelimumab in the studies retrieved was 2052. Conclusion. The combination of Durvalumab plus Tremelimumab showed some oncological advantages in comparison with traditional chemotherapies in some subsets of tumors, but generally have not shown consistent advantages in comparison with the employment of Durvalumab monotherapy. A number of the studies examined presented intrinsic methodological limitations, therefore future well-designed studies involving larger cohorts are warranted.
... Colorectal cancer (CRC) is one of the most common malignancies worldwide with a progressive increase in the global incidence and prevalence in the last decades [1,2]. Despite the recent improvements in the multimodality management of the disease, and the introduction of precision oncological therapies based on specific molecular biomarkers, CRC is characterized by high mortality rates, especially in advanced stage patients [3,4]. ...
Article
Full-text available
Purpose The pathological, clinical, and therapeutic features of colorectal cancer (CRC) depend on its anatomical localization. We investigated possible associations between the red blood cell distribution width (RDW) and CRC localization. Methods Two-hundred eighty-eight consecutive patients with CRC were retrospectively studied. Demographic, clinical, pathological and laboratory data were retrieved from clinical records and reports. Results Median RDW values were significantly higher in patients with right-sided CRC when compared to those with CRC in other localizations (16.2, IQR: 14.5–20.0 vs 13.8, IQR: 13.0–16.1, p < 0.0001). Anisocytosis was statistically associated to haemoglobin (Hb), mean haemoglobin concentration (MHC), and mean corpuscular volume (MCV) values in all the patient groups examined. A cut-off value of 14.3% was associated with right-sided localization with sensitivity and specificity of 76.3% and 64.2%, respectively (AUC 0.71). Conclusion Median RDW values were significantly higher in right-sided CRC when compared to other tumour locations, and may represent an additional marker for differential diagnosis.
... GISTs with little or no malignant features smaller than 1 cm are very frequent in subjects younger than 50. Nevertheless, larger clinically manifested GISTs are rare, especially when compared with the epithelial counterpart of digestive tract tumors like colorectal carcinomas, representing the 1% of all the gastrointestinal malignancies, with an annual incidence of about 1/100 000 individuals (Ridolfini et al., 2011;Palmieri et al., 2013;Metaxas et al., 2016). ...
Article
Background: Cervical cancer has a high mortality rate worldwide; in Pakistan it kills more than 7000 women every year. Prevention is possible through vaccination against human papilloma virus, the causative agent of cervical cancer, or by screening for premalignant lesions through routine Pap smear tests. We have studied the knowledge and practices regarding cervical cancer, its risk factors, screening and prevention and the role of human papilloma virus vaccination and Pap smear testing, among young women of Karachi. Methods: Information was gathered using a modified version of Cervical Cancer Awareness Measure Toolkit version 2.1 from 384 women aged 15 to 50 with no medical background attending outpatient clinics of AKUH, Karachi. Data entry was done through EpiData and analysis was done using SPSS version 22.0. Results: Our respondents' mean age was 30 (±7.6) years. Out of the 61.2% of women who had heard about cervical cancer, 47.0% had heard about Pap smear test and among them, 73% had gotten a Pap test. A total of 25.5% of women out of the 61.2%, knew that a vaccine existed for prevention and out of them only 9.8% had vaccinated against human papilloma virus. Conclusion: Majority of women in our study belonged to a higher socioeconomic class and were mostly educated but their knowledge and practices regarding prevention and screening of cervical cancer were poor. This reflects that the knowledge levels as a whole would be considerably lower in the city's general population.
... GISTs with little or no malignant features smaller than 1 cm are very frequent in subjects younger than 50. Nevertheless, larger clinically manifested GISTs are rare, especially when compared with the epithelial counterpart of digestive tract tumors like colorectal carcinomas, representing the 1% of all the gastrointestinal malignancies, with an annual incidence of about 1/100 000 individuals (Ridolfini et al., 2011;Palmieri et al., 2013;Metaxas et al., 2016). ...
Article
Full-text available
Objective. Gastrointestinal stromal tumor (GIST) is the most common mesenchymal malignancy of the gastrointestinal tract. We provide in the present article the molecular characterization of a series of primary GISTs in a cohort of Sardinian patients (Italy), with the aim to describe the patterns of KIT and PDGFRa mutations and the corresponding clinical features. Methods. Nighty-nine Sardinian patients with histologically-proven diagnosis of GIST were included in the study. Medical records and pathology reports were used to assess the demographic and clinical features of the patients and the disease at the time of the diagnosis. Formalin-fixed, paraffin-embedded tissue samples were retrieved for each case, and mutation analysis of the KIT and PDGFRa genes was performed. Results. KIT and PDGFRa mutations were detected in 81.8% and 5% of the cases, respectively. The most common KIT mutation was W557_K558del in exon 11, while D842V in exon 18 was the most common PDGFRa genetic alteration; V561D was the only PDGFRa mutation found in exon 12. The global “wild-type” cases, with no mutations in either the KIT or PDGFRa genes, were 13 (13.1%). The mean survival of those patients was approximately 46.9 (±43.9) months, without any statistical difference between mutated and wild-type cases. Conclusions. Globally, 86.9% of Sardinian patients with GIST had a KIT or PDGFRa mutation; the former were more frequent in comparison with other Italian cohorts, while PDGFRa mutations were rare. No statistical differences in survival between mutated and wild-type cases, and between KIT and PDGFRa mutated cases were detected in our study.
... Colorectal cancer (CRC) is one of the most incident malignancies worldwide 1 . Currently, a multidisciplinary approach is used for its evaluation and treatment, includ- ing surgeons, gastroenterologists, pathologists, oncolo- gists, radiotherapists and others 2 . ...
Article
Aim: One of the most serious complications in modern colorectal surgery is the occurrence of an anastomotic dehiscence. The aim of this study was to evaluate the role of preoperative red cell distribution width (RDW) and mean platelet volume (MPV) as predictors of anastomotic dehiscence in elective surgery for colorectal cancer. Materials and methods: Forty-two patients with a clinically manifested anastomotic dehiscence after oncological colorectal surgery, and 42 controls matched for age, sex, pathological stage and tumor localization were enrolled. Correlations between the preoperative RDW and MPV values and anastomotic dehiscence were investigated. Results: Both the median RDW value (14.4 % vs 13.1%; p=0.007) and the median MPV value (8.0 fL vs 7.5 fL; p=0.037) were significantly higher in patients with anastomotic dehiscence than in those without. In multiple regression analysis only the RDW remained significantly associated with anastomotic dehiscence. Conclusions: The preoperative values of RDW may be useful in predicting anastomotic damage in elective oncological surgery. Key words: Anastomotic Dehiscence, MPV, RDW.
... In Europe, 446 000 new cases of colorectal cancer are diagnosed each year (Kearney and Richarson, 2006), the average incidence being 40 per 100 000 men and 25 for every 100 000 women (Palmieri et al, 2013). Mortality is high (approximately 214 000 deaths per year) (Ferlay et al, 2013), and colorectal cancer is the second most common cause of death in Europe for both genders (Ouakrim et al, 2015). ...
Article
Full-text available
Aims/objectives: To analyse the relevance in clinical practice of factors reviewed in previous studies that define the experience of people with a stoma (ostomates), through the opinions of stoma care nurses. Method: Categories and thematic statements were reviewed by stoma care nurses using a modified Delphi method. They assessed the clinical relevance of the previously identified issues by measuring the intensity of the described situations within their practice. Results: Social impact was the most significant issue. Other relevant aspects were ‘description of disease’, ‘interaction with mutual help groups’, ‘health education’ and ‘consultation with professionals to improve self-care’, among others. In view of these results, an explanatory model was proposed whose central category was the ‘necessity of educating ostomates’, assuming that, if it is mediated by stoma care nurses in combination with others (such as mutual help groups), it will have a positive impact on the promotion of self-care, and it would reduce the negative impact of the stoma. Conclusions: The social dimension was the most outstanding area in the care of ostomates. Patients were afraid of social relationships, triggering situations of isolation and limiting their exposure to unfamiliar environments. If precautions related to stoma care are maintained, it will allow them to live a life without these limitations.
... Colorectal cancer (CRC) is one of the most common neoplastic diseases in the world with more than 1,200,000 annual cases estimated 1 risk factors, while the 5-years survival after chemotherapy alone is approximately 10-11% [5][6][7][8][9][10][11] . Several factors may influence the outcomes of CRCLM resections, like the number and volume of the hepatic lesions, their anatomical localization, and the timing of their detection in relation to the diagnosis of the primary CRC. ...
Article
Full-text available
Aim: To evaluate the impact of several clinical and pathological factors on the outcomes of surgery for hepatic colorectal cancer metastasis. Methods: Eighty-four liver metastasectomies in 77 consecutive patients with 90 colorectal cancer hepatic metastases were performed in our institution from 2009 to 2014. Surgery was carried out in 75 cases, as two patients were not eligible for surgery. Among them 43 (Group A) were affected by synchronous, and 32 (Group B) by metachronous lesions. Furthermore, 9 reoperations were performed in patients with initially synchronous lesions. The follow-up after surgery included total body CT scans every 3 months for the first year, and every 6 months for 4 years thereafter. Blood level of CEA was determined every 3 months. Results: The univariate analysis evidenced significantly more recurrences in patients with synchronous lesions (p=0.011), and higher grade, pN stage and CEA blood levels. In multivariate logistic regression analysis the statistically significant parameters found were: the pT stage (OR: 3.92, p = 0.039), the use of adjuvant chemotherapy for the colonic tumor (OR: 0.19, p = 0.025), and the adjuvant chemotherapy (OR: 4.11, p = 0.048). The global survival was 32 patients (41.5%), 17 with synchronous and 15 with metachronous lesions, and a significant difference in long term survival between these two groups was found (p = 0.008). Conclusions: The most relevant prognostic factor in patients with hepatic colorectal cancer dissemination is the timing of metastasis; the metachronous lesions present better survival when surgically treated. Key words: Colorectal cancer, Liver, Metastasis, Surgery.
Article
Full-text available
Background Monitoring cancer trends in a population is essential for tracking the disease’s burden, allocating resources, and informing public health policies. This review describes variations in commonly employed methods to estimate colorectal cancer (CRC) incidence trends. Methods We performed a systematic literature search in four databases to identify population-based studies reporting CRC incidence trends, published between January 2010 and May 2020. We extracted and described data on methods to estimate trends and assess model validity, and the software used. Results This review included 145 articles based on studies conducted in five continents. The majority (93%) presented visual summaries of trends combined with absolute, relative, or annual change estimates. Fourteen (10%) articles exclusively calculated the relative change in incidence over a given time interval, presented as the percentage of change in rates. Joinpoint regression analysis was the most commonly used method for assessing incidence trends (n= 65, 45%), providing estimates of the annual percentage change (APC) in rates. Nineteen (13%) studies performed Poisson regression and 18 (12%) linear regression analysis. Age-period-cohort modeling- a type of generalized linear models- was conducted in 18 (12%) studies. Thirty-nine (37%) of the studies modeling incidence trends (n=104, 72%) indicated the method used to evaluate model fitness. The joinpoint program (52%) was the statistical software most commonly used. Conclusion This review identified variation in the calculation of CRC incidence trends and inadequate reporting of model fit statistics. Our findings highlight the need for increasing clarity and transparency in reporting methods to facilitate interpretation, reproduction, and comparison with findings from previous studies.
Article
Full-text available
Background Epidemiological studies of incidence play an essential role in quantifying disease burden, resource planning, and informing public health policies. A variety of measures for estimating cancer incidence have been used. Appropriate reporting of incidence calculations is essential to enable clear interpretation. This review uses colorectal cancer (CRC) as an exemplar to summarize and describe variation in commonly employed incidence measures and evaluate the quality of reporting incidence methods. Methods We searched four databases for CRC incidence studies published between January 2010 and May 2020. Two independent reviewers screened all titles and abstracts. Eligible studies were population-based cancer registry studies evaluating CRC incidence. We extracted data on study characteristics and author-defined criteria for assessing the quality of reporting incidence. We used descriptive statistics to summarize the information. Results This review retrieved 165 relevant articles. The age-standardized incidence rate (ASR) (80%) was the most commonly reported incidence measure, and the 2000 U.S. standard population the most commonly used reference population (39%). Slightly more than half (54%) of the studies reported CRC incidence stratified by anatomical site. The quality of reporting incidence methods was suboptimal. Of all included studies: 45 (27%) failed to report the classification system used to define CRC; 63 (38%) did not report CRC codes; and only 20 (12%) documented excluding certain CRC cases from the numerator. Concerning the denominator estimation: 61% of studies failed to state the source of population data; 24 (15%) indicated census years; 10 (6%) reported the method used to estimate yearly population counts; and only 5 (3%) explicitly explained the population size estimation procedure to calculate the overall average incidence rate. Thirty-three (20%) studies reported the confidence interval for incidence, and only 7 (4%) documented methods for dealing with missing data. Conclusion This review identified variations in incidence calculation and inadequate reporting of methods. We outlined recommendations to optimize incidence estimation and reporting practices. There is a need to establish clear guidelines for incidence reporting to facilitate assessment of the validity and interpretation of reported incidence.
Article
Full-text available
We present the main results of the sixth survey of the Italian screening programmes for colorectal cancer carried out by the National centre for screening monitoring (Osservatorio nazionale screening, ONS) on behalf of the Ministry of health. By the end of 2009, 98 programmes were active, of which 13 had been activated during the year, and 59% of Italians aged 50-69 years were residing in areas covered by organised screening programmes (theoretical extension). Eleven regions had their whole population covered. In the South of Italy and Islands, 4 new programmes were activated in 2009, with a theoretical extension of 22%. The majority of programmes employ the faecal occult blood test (FOBT), while some have adopted flexible sigmoidoscopy (FS) once in a lifetime and FOBT for non-responders to FS. Overall, about 2,935,000 subjects were invited to undergo FOBT, 40% of those to be invited within the year. The adjusted attendance rate was 50% and approximately 1,426,000 subjects were screened. Large differences in the attendance rate were observed among regions, with 10% of programmes reporting values lower than 29%. Positivity rate of FOBT programmes was 5.6% at first screening (range: 2.5-12.4%) and 4.2% at repeat screening (range: 2.5-7.3%). The average attendance rate to total colonoscopy (TC) was 82.5%and in one region it was lower than 70%. Completion rate for total colonoscopy (TC) was 91.2%. Among the 631,460 subjects attending screening for the first time, the detection rate (DR) per 1,000 screened subjects was 2.4 for invasive cancer and 11.6 for advanced adenomas (AA - adenomas with a diameter ≥ 1 cm, with villous/tubulo-villous type or with high-grade dysplasia). As expected, the corresponding figures in the 824,562 subjects at repeat screening were lower (1.3‰ and 7.6‰ for invasive cancer and AA, respectively). The DR of cancer and adenomas increased with age and was higher among males. Many programmes reported some difficulties in guaranteeing TC in the appropriate time frame to FOBT+ subjects: in 16% of cases the waiting time was longer than two months. Nine programmes employed FS as the screening test: 65% of the target population (about 60,000 subjects) were invited and 9 511 subjects were screened, with an attendance rate of 24.3%. Overall, 81% of FS were classified as complete. Overall TC referral rate was 11% and the DR per 1,000 screened subjects was 2.6 and 43.7 for invasive cancer and AA, respectively.
Article
Full-text available
Introduction The Bowel Cancer Screening Programme in England began operating in 2006 with the aim of full roll out across England by December 2009. Subjects aged 60–69 are being invited to complete three guaiac faecal occult blood tests (6 windows) every 2 years. The programme aims to reduce mortality from colorectal cancer by 16% in those invited for screening. Methods All subjects eligible for screening in the National Health Service in England are included on one database, which is populated from National Health Service registration data covering about 98% of the population of England. This analysis is only of subjects invited to participate in the first (prevalent) round of screening. Results By October 2008 almost 2.1 million had been invited to participate, with tests being returned by 49.6% of men and 54.4% of women invited. Uptake ranged between 55–60% across the four provincial hubs which administer the programme but was lower in the London hub (40%). Of the 1.08 million returning tests 2.5% of men and 1.5% of women had an abnormal test. 17 518 (10 608 M, 6910 F) underwent investigation, with 98% having a colonoscopy as their first investigation. Cancer (n=1772) and higher risk adenomas (n=6543) were found in 11.6% and 43% of men and 7.8% and 29% of women investigated, respectively. 71% of cancers were ‘early’ (10% polyp cancer, 32% Dukes A, 30% Dukes B) and 77% were left-sided (29% rectal, 45% sigmoid) with only 14% being right-sided compared with expected figures of 67% and 24% for left and right side from UK cancer registration. Conclusion In this first round of screening in England uptake and fecal occult blood test positivity was in line with that from the pilot and the original European trials. Although there was the expected improvement in cancer stage at diagnosis, the proportion with left-sided cancers was higher than expected.
Article
Full-text available
This study aimed to analyze the incidence of colorectal cancer in 15 European countries in recent decades and the relationship between the incidence found and changes in dietary habits. Pearson's or Spearman's correlation coefficients were calculated by comparing incidence rates obtained from the International Agency for Research on Cancer for 1971-2002 with data on per capita consumption obtained from the Food and Agriculture Organization of the United Nations using 10-year delay intervals. Incidence rates increased in all countries except France in men and except Austria, Denmark, England and France in women. Of the dietary variables considered, there were marked increasing trends (linear regression coefficient, R ≥0.5) in red meat consumption in Germany (R = 0.9), Austria (R = 0.7), Finland (R = 0.8), Italy (R = 0.9), Poland (R = 0.5), Spain (R = 2.1), Sweden (R = 0.6), and the Netherlands (R = 0.7). Changes in dietary habits may be consistent with the observed trends in the incidence of colorectal cancer in the distinct European countries.
Article
Full-text available
We present the main results from the fifth survey of the Italian screening programmes for colorectal cancer carried out by the National Centre for Screening Monitoring (Osservatorio Nazionale Screening, ONS) on behalf of the Ministry of Health. By the end of 2008, 87 programmes were active (14 had been activated during the year), and 52,9%of Italians aged 50- 69 years were residing in areas covered by organised screening programmes (theoretical extension). Ten Regions had their whole population covered. In the South of Italy and Islands, 12 new programmes were activated in 2008, including those of Abruzzo and Molise Regions, with an increase of theoretical extension from 7% to 21%. The majority of programmes employ the faecal occult blood test (FOBT), while some have adopted flexible sigmoidoscopy (FS) once in a lifetime, or a combination of both. Overall, about 2,593,000 subjects were invited to undergo FOBT, 71%of those to be invited within the year. The adjusted attendance rate was 47.5% and approximately 1,171,000 subjects were screened. Large differences in the attendance rate were observed among Regions, with 10% of programmes reporting values lower than 30%. Positivity rate of FOBT programmes was 5.9% at first screening (range 2.0-11%) and 4% at repeat screening (range 2.9-6.5%). The average attendance rate for total colonoscopy (TC) was 81.3% and in three Regions it was lower than 70%. Completion rate of TC was 92.2%. Among the 665,264 subjects attending screening for the first time, the detection rate (DR) per 1,000 screened subjects was 2.7 for invasive cancer and 13.1 for advanced adenomas (AA, adenomas with a diameter ≥1 cm, with villous/ tubulo-villous type or with high-grade dysplasia). As expected, the corresponding figures in the 552,391 subjects at repeat screening were lower (1.3‰ and 8.3‰ for invasive cancer and AA, respectively). The DR of cancer and adenomas increased with age and was higher among males. Many programmes reported some difficulties in guaranteeing TC in the appropriate time frame to FOBT+ subjects: in 16.0% of cases the waiting time was longer than two months. Seven programmes employed FS as the screening test: 58.8% of the target population (about 50,000 subjects) were invited and 8,135 subjects were screened, with an attendance rate of 27.2%. Overall, 83% of FS were classified as complete. Overall TC referral rate was 13.5% and the DR per 1,000 screened subjects was 4.7 and 47.5 for invasive cancer and AA, respectively.
Article
Full-text available
In this article, the incidence, mortality, and survival rates for colorectal cancer are reviewed, with attention paid to regional variations and changes over time. A concise overview of known risk factors associated with colorectal cancer is provided, including familial and hereditary factors, as well as environmental lifestyle-related risk factors such as physical inactivity, obesity, smoking, and alcohol consumption.
Article
Full-text available
Colorectal cancer (CRC) is the second most frequent malignant disease in Europe. Every year, 412 000 people are diagnosed with this condition, and 207 000 patients die of it. In 2003, recommendations for screening programs were issued by the Council of the European Union (EU), and these currently serve as the basis for the preparation of European guidelines for CRC screening. The manner in which CRC screening is carried out varies significantly from country to country within the EU, both in terms of organization and the screening test chosen. A screening program of one sort or another has been implemented in 19 of 27 EU countries. The most frequently applied method is testing stool for occult bleeding (fecal occult blood test, FOBT). In recent years, a screening colonoscopy has been introduced, either as the only method (Poland) or the method of choice (Germany, Czech Republic).
Article
In terms of new diagnoses, colorectal cancer is one of the most important cancers in Italy and worldwide. The aim of this paper is to present estimates of the mortality, incidence and prevalence of colorectal cancer in Italy at a national and regional scale over the period 1970-1999, with projections up to 2010. The estimates were obtained by applying the MIAMOD method, a statistical back-calculation approach to derive incidence and prevalence estimates from mortality and relative survival data. Published data from the Italian cancer registries were modelled to obtain regional and national estimates of colorectal cancer survival. Different incidence patterns were observed for men and women, especially in the projection period: the national age-standardized rate is estimated to increase throughout the study period 1970-2010 for men from 30 to 70 per 100,000, and to stabilize from the end of the 1990s for women at around 38 per 100,000. A stabilization or a slight decrease in age-standardized incidence rates is expected in most regions for women and in most northern-central regions for men. The most critical situation is estimated among men for southern regions, where the rise in incidence is accompanied by a dramatic increase in mortality. About 46,000 incident cases, 267,000 prevalent cases, and 16,000 deaths from colorectal cancer are estimated in Italy for the year 2005. Despite the risk reduction estimated in most northern-central regions among men and in the large majority of regions among women, the colorectal cancer burden in Italy is expected to remain relevant in the next years. Prospects for reducing this burden appear mainly connected to the adoption of prevention policies aimed at increasing the awareness of the risk related to dietary habits and lifestyles and at promoting colorectal cancer screening.
Article
Reducing mortality from colorectal cancer (CRC) may be achieved by the introduction of population-based screening programs. The aim of the systematic review was to update previous research to determine whether screening for CRC using the fecal occult blood test (FOBT) reduces CRC mortality and to consider the benefits, harms, and potential consequences of screening. We searched eight electronic databases (Cochrane Library, MEDLINE, EMBASE, CINAHL, PsychINFO, AMED, SIGLE, and HMIC). We identified nine articles describing four randomized controlled trials (RCTs) involving over 320,000 participants with follow-up ranging from 8 to 18 yr. The primary analyses used intention to screen and a secondary analysis adjusted for nonattendance. We calculated the relative risks and risk differences for each trial, and then overall, using fixed and random effects models. Combined results from the four eligible RCTs indicated that screening had a 16% reduction in the relative risk (RR) of CRC mortality (RR 0.84, 95% confidence interval [CI] 0.78-0.90). There was a 15% RR reduction (RR 0.85, 95% CI 0.78-0.92) in CRC mortality for studies that used biennial screening. When adjusted for screening attendance in the individual studies, there was a 25% RR reduction (RR 0.75, 95% CI 0.66-0.84) for those attending at least one round of screening using the FOBT. There was no difference in all-cause mortality (RR 1.00, 95% CI 0.99-1.02) or all-cause mortality excluding CRC (RR 1.01, 95% CI 1.00-1.03). The present review includes seven new publications and unpublished data concerning CRC screening using FOBT. This review confirms previous research demonstrating that FOBT screening reduces the risk of CRC mortality. The results also indicate that there is no difference in all-cause mortality between the screened and nonscreened populations.